Search by Drug Name or NDC
NDC 55150-0164-02 Lidocaine Hydrochloride 20 mg/mL Details
Lidocaine Hydrochloride 20 mg/mL
Lidocaine Hydrochloride is a EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 55150-0164 |
|---|---|
| Product ID | 55150-164_1d827eb4-623d-4ffa-b95e-43de66de07a2 |
| Associated GPIs | 69100040102021 |
| GCN Sequence Number | 060674 |
| GCN Sequence Number Description | lidocaine HCl/PF VIAL 20 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 26885 |
| HICL Sequence Number | 033592 |
| HICL Sequence Number Description | LIDOCAINE HCL/PF |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203082 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0164-02 (55150016402)
| NDC Package Code | 55150-164-02 |
|---|---|
| Billing NDC | 55150016402 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-164-02) / 2 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2013-03-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |